Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeting Antibiotics to Pseudomonas Aeruginosa in Small Airways (TAPAS) PK Study in Cystic Fibrosis
2013-004488-30Phase 4Active
- Sponsor
- HagaZiekenhuis
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Systemic bioavailability of inhaled tobramycin (AUC0-24hr). Started Dec 2013; status: active.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on 2013-004488-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004488-30.